Imax Corp (NYSE: IMAX) has a price-to-earnings ratio of 38.46x that is above its average ratio. Additionally, the 36-month beta value for IMAX is 1.20. There are mixed opinions on the stock, with 7 ...

General Dynamics Corp. (NYSE: GD) has a price-to-earnings ratio of 22.96x that is above its average ratio. Additionally, the 36-month beta value for GD is 0.66. There are mixed opinions on the stock, ...

Sociedad Quimica Y Minera de Chile S.A. ADR (NYSE: SQM) has a price-to-earnings ratio of 6.15x that is above its average ratio. Additionally, the 36-month beta value for SQM is 1.12. There are mixed ...

Nash Huw M., the COO & CBO of Stoke Therapeutics Inc, sale 61,329 shares at $13.23 during a trade that took place back on Apr 01 ’24, which means that Nash Huw M. is holding 0 shares at $811,212 based ...

Based on Ideaya Biosciences Inc (IDYA), the company’s capital structure generated 0.0 points at debt to capital in total, while cash flow to debt ratio is standing at -40.12. The debt to equity ratio ...

Evotec SE ADR (NASDAQ: EVO)’s stock price has dropped by -31.26 in relation to previous closing price of 7.65. Nevertheless, the company has seen a loss of -27.36% in its stock price over the last ...

To wrap up, the performance of Heart Test Laboratories Inc. (HSCS) has been bad in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It’s important to note that ...

The stock of AdTheorent Holding Company Inc (ADTH) has seen a 0.63% increase in the past week, with a -3.89% drop in the past month, and a 15.47% flourish in the past quarter. The volatility ratio for ...

Steinhart Richard I, the Chief Financial Officer of BioXcel Therapeutics Inc, sale 1,069 shares at $2.63 during a trade that took place back on Apr 04 ’24, which means that Steinhart Richard I is ...

The price-to-earnings ratio for Cars.com (NYSE: CARS) is above average at 9.74x. The 36-month beta value for CARS is also noteworthy at 2.06. There are mixed opinions on the stock, with 1 analysts ...

During the last 5 trading sessions, TROO rose by +42.04%, which changed the moving average for the period of 200-days by -65.29% in comparison to the 20-day moving average, which settled at $1.2285.

The price-to-earnings ratio for XPO Inc (NYSE: XPO) is 70.32x, which is above its average ratio. Moreover, the 36-month beta value for XPO is 2.18. Analysts have varying opinions on the stock, with 12 ...